Aspirin therapy in nonarteritic anterior ischemic optic neuropathy

American Journal of Ophthalmology

Volumn 123, Issue 2, 1997, Pages 212-217

  Beck, R W ^a   Sohan Singh Hayreh, ^a   Podhajsky, P A ^a   Tan, E S ^a   Moke, P S ^a  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; DRUG EFFECT; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; ISCHEMIC OPTIC NEUROPATHY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS;

EID: 0031034228     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)71038-4     Document Type: Article

References (6)

1. SS Hayreh KM Joos PA Podhajsky CR. Long Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy Am J Ophthalmol 118 1994 766 780
2. M Beri MR Klugman JA Kohler SS. Hayreh Anterior ischemic optic neuropathy, VII: incidence of bilaterality and various influencing factors Ophthalmology 94 1987 1020 1028
3. MS Repka PJ Savino NJ Schatz RC. Sergott Anterior ischemic optic neuropathy: clinical profile and long-term prognosis Am J Ophthalmol 96 1983 478 483
4. DR Boghen JS. Glaser Ischemic optic neuropathy: the clinical profile and natural history Brain 98 1975 689 708
5. M Sanderson M Kupersmith L Frohman Aspirin reduces anterior ischemic optic neuropathy in the second eye ARVO abstracts. Invest Ophthalmol Vis Sci 36 4,suppl 1995 S196
6. Ischemic Optic Neuropathy Decompression Trial Research Group Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (AION) is not effective and may be harmful JAMA 273 1995 625 632